ustekinumab-srlf - Drug Details
๐Ÿ“Š Estimates ustekinumab-srlf Dialyzability By Different_Modalities

ustekinumab-srlf

Complete Drug Information

Drug Name
ustekinumab-srlf
Trade Names
Stelara
Pregnancy Category
AU: B1
Routes of Administration
Subcutaneous, intravenous
Metabolism
unknown
Elimination
15โ€“32 days (average 3 weeks)
Formula
C6482H10004N1712O2016S46
Molar Mass
145648.06
Drug Class
Immunosuppressant interleukin inhibitor
Volume of Distribution
C6482H10004N1712O2016S46

๐Ÿคฐ Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.